Selected publications

1. Pennycuick A, Teixeira VH, AbdulJabbar K, Raza SEA, Lund T, Akarca AU, Rosenthal R, Kalinke L, Chandrasekharan DP, Pipinikas CP, Lee-Six H, Hynds RE, Gowers KHC, Henry JY, Millar FR, Hagos YB, Denais C, Falzon M, Moore DA, Antoniou S, Durrenberger PF, Furness AJ, Carroll B, Marceaux C, Asselin-Labat ML, Larson W, Betts C, Coussens LM, Thakrar RM, George J, Swanton C, Thirlwell C, Campbell PJ, Marafioti T, Yuan Y, Quezada SA, McGranahan N, Janes SM. Immune Surveillance in Clinical Regression of Preinvasive Squamous Cell Lung Cancer. Cancer Discov. 2020 Oct;10(10):1489-1499. PMID: 32690541
2. Leong TL, Gayevskiy V, Steinfort DP, De Massy, MR, Gonzalez-Rajal, A, Marini KD, Stone E, Chin V, Havryk A, Plit M, Irving LB, Jennings BR, McCloy RA, Jayesekara WSN, Alamgeer M, Bolell V, Field A, Russell PA, Kumar B, Gough DJ, Szczepny A, Ganju V, Rossello FJ, Cian E, Pappenfuss AT, Asselin-Labat ML*, Cowley MJ*, Watkins DN*. Deep multi-region whole-genome sequencing reveals heterogeneity and gene-by-environment interactions in treatment-naive metastatic lung cancer. 2019 Oncogene, March 01; 38(10):1661-1675. PMID: 30348992
3. Iglesias-Bartolome R, Abusleme L, Molinolo AA, Uchiyama A, Brooks SR, Callejas-Valera JL, Moutsopoulos N, Edwards D, Asselin-Labat ML, Onaitis M, Doci C, Gutkind JS, Morasso M. Unique transcriptional signature primes oral mucosa for rapid wound healing in humans. Science Transl Med, 2018 Jul 25;10(451) PMID: 30045979
4. Weeden CE, Ah-Cann C, Holik AZ, Pasquet J, Garnier JM, Merino D, Lessene G, Asselin-Labat ML. Dual inhibition of BCL-XL and MCL-1 is required to induce tumour regression in lung squamous cell carcinomas sensitive to FGFR inhibition. Oncogene, 2018 Aug ;37(32) :4475-4488 PMID: 29743589
5. Weeden CE, Holik AZ, Young RJ, Ma SB, Garnier JM, Fox SB, Antippa P, Irving LB, Steinfort DP, Wright GM, Russell PA, Ritchie ME, Burns CJ, Solomon B, Asselin-Labat ML. Cisplatin increases sensitivity to FGFR inhibition in patient-derived xenograft models of lung squamous cell carcinoma. Mol Cancer Ther. 2017 Aug; 16(8):1610-1622. PMID: 28611104
6. Weeden CE, Chen Y, Ma SB, Hu Y, Ramm G, Sutherland KD, Smyth GK, Asselin-Labat ML. Lung Basal Stem Cells Rapidly Repair DNA Damage Using the Error-Prone Nonhomologous End-Joining Pathway. PLoS Biol 2017 Jan 26 15(1):e2000731. PMID: 28125611
7. Holik AZ, Filby CE, Pasquet J, Viitaniemi K, Ciciulla J, Sutherland KD and Asselin-Labat ML. The LIM-domain only protein 4 contributes to lung epithelial cell proliferation but is not essential for tumor progression. Respir Res. 2015 Jun 7; 16:67. PMID: 26048572
8. Galvis L, Holik AZ, Short KM, Pasquet J, Lun AL, Blewitt ME, Smyth IM, Ritchie ME, Asselin-Labat ML. Repression of Igf1 expression by Ezh2 prevents basal cell differentiation in the developing lung. Development, 2015 Apr 15;142(8):1458-69. PMID: 25790853
9. Asselin-Labat ML, Vaillant F, Sheridan JM, Pal B, Wu D, Simpson ER, Yasuda H, Smyth GK, Martin TJ, Lindeman GJ, Visvader JE. Control of mammary stem cell function by steroid hormone signalling. Nature. 2010 Jun 10;465(7299):798-802. PMID: 20383121
10. Asselin-Labat ML, Sutherland KD, Barker H, Thomas R, Shackleton M, Forrest NC, Hartley L, Robb L, Grosveld FG, van der Wees J, Lindeman GJ, Visvader JE. Gata-3 is an essential regulator of mammary-gland morphogenesis and luminal-cell differentiation. Nat Cell Biol. 2007 Feb;9(2):201-9. PMID: 17187062

Further publications